DermBiont

DermBiont, Inc. is a Boston, Massachusetts clinical-stage dermatology therapeutics company founded in 2017 that develops targeted topical treatments addressing the root cause of skin disease rather than its symptoms. Its lead program SM-030 is a first-in-class topical PKC-beta inhibitor in development for melasma and other hyperpigmentation disorders of the skin, targeting excess melanin production; earlier programs included SM-020 for seborrheic keratosis and the live-bacterial DBI-001 and DBI-002 candidates for atopic dermatitis, tinea pedis and onychomycosis. The company describes an in-house discovery platform for microbiome-based therapeutics built on terabytes of DNA sequencing data from human skin samples across healthy individuals and patients, paired with a proprietary computational biology platform that identifies functions gained and lost by the skin microbiome. That computational platform is internal research tooling, not a product: DermBiont sells drug candidates and partnering opportunities, publishes no developer program, no public API, no SDK and no machine-readable API contract of any kind, and its website is a Squarespace-hosted corporate site.

DermBiont is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Dermatology, and Therapeutics.

DermBiont’s developer surface includes support and 11 more developer resources.

🌐 Visit website 📡 Source on GitHub

5.0/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-09-08 · rubric v0.20.0

0 APIs

Company Biotechnology Pharmaceuticals Dermatology TherapeuticsSkin MicrobiomeMicrobiome Drug Discovery Clinical Stage Life Sciences Health

Kin Score

Kin Score How this is scored →
scored 2026-09-08 · rubric v0.20.0

Composite quality — 5.0/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.8 / 17

Access Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Well-Known Document 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/dermbiont: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Dermbiont Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 2

Status, limits, changes, and where to get help

Contact

Contact

Support

Support

Company 4

The organization behind the API

Website

Website

About

About

LinkedIn

Crunchbase

Crunchbase

Other 4

Properties that don't map to a standard resource type

Product

Platform

Pipeline

Leadership

Source (apis.yml)

aid: dermbiont
name: DermBiont
description: 'DermBiont, Inc. is a Boston, Massachusetts clinical-stage dermatology therapeutics company founded in 2017 that
  develops targeted topical treatments addressing the root cause of skin disease rather than its symptoms. Its lead program
  SM-030 is a first-in-class topical PKC-beta inhibitor in development for melasma and other hyperpigmentation disorders of
  the skin, targeting excess melanin production; earlier programs included SM-020 for seborrheic keratosis and the live-bacterial
  DBI-001 and DBI-002 candidates for atopic dermatitis, tinea pedis and onychomycosis. The company describes an in-house discovery
  platform for microbiome-based therapeutics built on terabytes of DNA sequencing data from human skin samples across healthy
  individuals and patients, paired with a proprietary computational biology platform that identifies functions gained and
  lost by the skin microbiome. That computational platform is internal research tooling, not a product: DermBiont sells drug
  candidates and partnering opportunities, publishes no developer program, no public API, no SDK and no machine-readable API
  contract of any kind, and its website is a Squarespace-hosted corporate site.'
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
image: https://static1.squarespace.com/static/5be33300f93fd46b40da5761/t/629e316bea93f12ec9cc272d/1654534507403/DM-main-logo.png?format=1500w
url: https://raw.githubusercontent.com/api-evangelist/dermbiont/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Dermatology
- Therapeutics
- Skin Microbiome
- Microbiome
- Drug Discovery
- Clinical Stage
- Life Sciences
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/dermbiont-domain-security.yml
- type: Website
  url: https://www.dermbiont.com/
- type: About
  url: https://www.dermbiont.com/overview
- type: Product
  url: https://www.dermbiont.com/platform
- type: Platform
  url: https://www.dermbiont.com/dermatology-platform
- type: Pipeline
  url: https://www.dermbiont.com/pipeline
- type: Leadership
  url: https://www.dermbiont.com/leadership
- type: Contact
  url: https://www.dermbiont.com/contact-us
- type: Support
  url: https://www.dermbiont.com/contact-us
- type: LinkedIn
  url: https://www.linkedin.com/company/dermbiont
- type: Crunchbase
  url: https://www.crunchbase.com/organization/dermbiont
- type: LLMsTxt
  url: llms/dermbiont-llms.txt
x-enrichment:
  date: '2026-08-12'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: DermBiont is a clinical-stage dermatology drug developer whose only product is the SM-030 topical candidate; its
    sole web property is a 30-page Squarespace corporate site with no developer, docs or API section anywhere in its sitemap,
    every OpenAPI, GraphQL, llms.txt and .well-known path returns 404, api.dermbiont.com does not resolve, and no GitHub organization
    or first-party package exists on any public registry.
  evidence:
  - url: https://www.dermbiont.com/openapi.json
    status: 404
  - url: https://www.dermbiont.com/graphql
    status: 404
  - url: https://www.dermbiont.com/llms.txt
    status: 404
  - url: https://www.dermbiont.com/.well-known/agent-card.json
    status: 404
  - url: https://www.dermbiont.com/.well-known/agent.json
    status: 404
  - url: https://www.dermbiont.com/.well-known/security.txt
    status: 404
  - url: https://api.github.com/orgs/dermbiont
    status: 404
  - url: https://www.dermbiont.com/sitemap.xml
    status: 200
  checked: '2026-08-12'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/dermbiont"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/dermbiont/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/dermbiont/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.